Health-related quality of life outcomes in chronic myeloid leukemia patients treated with second generation tyrosine kinase inhibitors: do we know enough?

被引：3
作者：
Breccia, Massimo [1 ]
Efficace, Fabio [2 ]
机构：
[1] Sapienza Univ, Dept Cellular Biotechnol & Hematol, Hematol, Rome, Italy
[2] Italian Grp Adult Hematol Dis GIMEMA, Data Ctr & Hlth Outcomes Res Unit, Rome, Italy
来源：
CURRENT MEDICAL RESEARCH AND OPINION | 2016年 / 32卷 / 08期
关键词：
CHRONIC PHASE; IMATINIB;
D O I：
10.1080/03007995.2016.1185399
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1453 / 1454
页数：2
相关论文
共 14 条
[1]   Time for a new era in the evaluation of targeted therapies for patients with chronic myeloid leukemia: Inclusion of quality of life and other patient-reported outcomes [J].
Efficace, F. ;
Cocks, K. ;
Breccia, M. ;
Sprangers, M. ;
Meyers, C. A. ;
Vignetti, M. ;
Baccarani, M. ;
Mandelli, F. .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2012, 81 (02) :123-135
[2]   Tyrosine-kinase inhibitors and patient-reported outcomes in chronic myeloid leukemia: A systematic review [J].
Efficace, Fabio ;
Cardoni, Annarita ;
Cottone, Francesco ;
Vignetti, Marco ;
Mandelli, Franco .
LEUKEMIA RESEARCH, 2013, 37 (02) :206-213
[3]   Health-related quality of life in chronic myeloid leukemia patients receiving long-term therapy with imatinib compared with the general population [J].
Efficace, Fabio ;
Baccarani, Michele ;
Breccia, Massimo ;
Alimena, Giuliana ;
Rosti, Gianantonio ;
Cottone, Francesco ;
Deliliers, Giorgio Lambertenghi ;
Barate, Claudia ;
Rossi, Antonella Russo ;
Fioritoni, Giuseppe ;
Luciano, Luigia ;
Turri, Diamante ;
Martino, Bruno ;
Di Raimondo, Francesco ;
Dabusti, Melissa ;
Bergamaschi, Micaela ;
Leoni, Pietro ;
Simula, Maria Pina ;
Levato, Luciano ;
Ulisciani, Stefano ;
Veneri, Dino ;
Sica, Simona ;
Rambaldi, Alessandro ;
Vignetti, Marco ;
Mandelli, Franco .
BLOOD, 2011, 118 (17) :4554-4560
[4]   Multicenter Independent Assessment of Outcomes in Chronic Myeloid Leukemia Patients Treated With Imatinib [J].
Gambacorti-Passerini, Carlo ;
Antolini, Laura ;
Mahon, Francois-Xavier ;
Guilhot, Francois ;
Deininger, Michael ;
Fava, Carmen ;
Nagler, Arnon ;
Della Casa, Chiara Maria ;
Morra, Enrica ;
Abruzzese, Elisabetta ;
D'Emilio, Anna ;
Stagno, Fabio ;
le Coutre, Philipp ;
Hurtado-Monroy, Rafael ;
Santini, Valeria ;
Martino, Bruno ;
Pane, Fabrizio ;
Piccin, Andrea ;
Giraldo, Pilar ;
Assouline, Sarit ;
Durosinmi, Muheez A. ;
Leeksma, Onno ;
Pogliani, Enrico Maria ;
Puttini, Miriam ;
Jang, Eunjung ;
Reiffers, Josy ;
Valsecchi, Maria Grazia ;
Kim, Dong-Wook .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2011, 103 (07) :553-561
[5]   Impact of low-grade adverse events on health-related quality of life in adult patients receiving imatinib or nilotinib for newly diagnosed Philadelphia chromosome positive chronic myelogenous leukemia in chronic phase [J].
Guerin, Annie ;
Chen, Lei ;
Ionescu-Ittu, Raluca ;
Marynchenko, Maryna ;
Nitulescu, Roy ;
Hiscock, Robert ;
Keir, Christopher ;
Wu, Eric Qiong .
CURRENT MEDICAL RESEARCH AND OPINION, 2014, 30 (11) :2317-2328
[6]   Quality of life in patients with newly diagnosed chronic phase chronic myeloid leukemia on imatinib versus interferon alfa plus low-dose cytarabine: Results from the IRIS study [J].
Hahn, EA ;
Glendenning, GA ;
Sorensen, MV ;
Hudgens, SA ;
Druker, BJ ;
Larson, RA ;
O'Brien, SG ;
Dobrez, DG ;
Hensley, ML ;
Cella, D .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (11) :2138-2146
[7]   Chronic myeloid leukemia (CML): association of treatment satisfaction, negative medication experience and treatment restrictions with health outcomes, from the patient's perspective [J].
Hirji, Ishan ;
Gupta, Shaloo ;
Goren, Amir ;
Chirovsky, Diana R. ;
Moadel, Alyson B. ;
Olavarria, Eduardo ;
Victor, Timothy W. ;
Davis, Catherine C. .
HEALTH AND QUALITY OF LIFE OUTCOMES, 2013, 11
[8]   Patient-reported adverse drug reactions and their influence on adherence and quality of life of chronic myeloid leukemia patients on per oral tyrosine kinase inhibitor treatment [J].
Kekale, Meri ;
Peltoniemi, Marikki ;
Airaksinen, Marja .
PATIENT PREFERENCE AND ADHERENCE, 2015, 9 :1733-1740
[9]  
Labeit AM, 2015, BLOOD, V126
[10]  
Lutge I, 2015, HAEMATOLOGICA S1, V100
12